デフォルト表紙
市場調査レポート
商品コード
1458406

乳房再建の世界市場:製品別、手技別、エンドユーザー別、地域別、機会、予測、2017年~2031年

Breast Reconstruction Market Assessment, By Product, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 225 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
乳房再建の世界市場:製品別、手技別、エンドユーザー別、地域別、機会、予測、2017年~2031年
出版日: 2024年04月01日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房再建の市場規模は、2024年~2031年の予測期間中に5.14%のCAGRで拡大し、2023年の10億1,000万米ドルから2031年には15億1,000万米ドルに成長すると予測されています。同市場は近年著しい成長を遂げており、今後も力強い拡大ペースを維持すると予想されます。世界の乳房再建市場の成長は、世界人口における乳がんの有病率の上昇や、世界全体での乳房再建手術件数の増加など、さまざまな要因によってもたらされます。技術の進歩、医療機器業界や外科業界を含むヘルスケアセクターの成長、公的機関や民間団体による啓発キャンペーンの増加が、この市場の世界の成長につながる要因です。さらに、有利な規制制度と償還政策、複数のトップ企業の存在と共同ベンチャー活動、新規参入、頻繁な製品発売は、世界の乳房再建市場の成長を加速させています。

世界の乳房再建市場は、主に世界人口の乳がん有病率の上昇により力強い成長を遂げています。この有病率の上昇に伴い、乳房切除術の実施件数も毎年増加しています。乳房再建は、乳房切除術の次に、乳房の形、大きさ、対称性、輪郭を復元するために不可欠なステップです。乳房再建の実施におけるAIの使用など、この業界における技術の進歩、主要企業による研究開発活動の増加は、世界の乳房再建市場をさらに加速させています。

有利な規制の枠組みとともに、市場参入企業による頻繁な製品の発売は、世界の乳房再建市場を後押しする上で極めて重要な役割を果たしています。乳房インプラントのFDA承認が増加し、患者の病状や手術結果の改善につながっています。さらに、M&A、パートナーシップ、組織間の販売契約などの一貫した協力活動は、さらに世界の乳房再建市場を推進しています。

当レポートでは、世界の乳房再建市場について調査し、市場の概要とともに、製品別、手技別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の乳房再建市場の見通し、2017年~2031年

  • 市場規模と予測
  • 手技別
  • 製品別
  • エンドユーザー別
  • 地域別
  • 企業別市場シェア(%)、2023年

第5章 世界の乳房再建市場の見通し(地域別、2017年~2031年)

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第6章 2023年の市場マッピング

第7章 マクロ環境と産業構造

  • 需要供給分析
  • 輸入輸出分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

  • Allergan Aesthetics
  • Sientra, Inc.
  • Medical Devices Business Services, Inc.
  • RTI Surgical, Inc.
  • Groupe SEBBIN SAS
  • Integra LifeSciences
  • GC Aesthetics
  • Mentor Worldwide LLC
  • Establishment Labs Holdings Inc.
  • Polytech Health & Aesthetics GmbH

第14章 戦略的提言

第15章 お問い合わせと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 3.Global Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 4.Global Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 5.Global Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Breast Reconstruction Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 9.North America Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 10.North America Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 11.North America Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 15.United States Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 16.United States Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 17.United States Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 20.Canada Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 21.Canada Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 22.Canada Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 25.Mexico Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 26.Mexico Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 27.Mexico Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 30.Europe Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 31.Europe Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 32.Europe Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 36.Germany Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 37.Germany Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 38.Germany Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 41.France Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 42.France Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 43.France Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 46.Italy Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 47.Italy Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 48.Italy Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 51.United Kingdom Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 52.United Kingdom Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 53.United Kingdom Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 56.Russia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 57.Russia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 58.Russia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 61.Netherlands Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 62.Netherlands Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 63.Netherlands Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 66.Spain Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 67.Spain Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 68.Spain Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 71.Turkey Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 72.Turkey Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 73.Turkey Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 76.Poland Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 77.Poland Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 78.Poland Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 81.South America Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 82.South America Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 83.South America Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 87.Brazil Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 88.Brazil Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 89.Brazil Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 92.Argentina Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 93.Argentina Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 94.Argentina Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 97.Asia-Pacific Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 98.Asia-Pacific Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 99.Asia-Pacific Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 101.India Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 103.India Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 104.India Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 105.India Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 108.China Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 109.China Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 110.China Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 113.Japan Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 114.Japan Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 115.Japan Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 118.Australia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 119.Australia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 120.Australia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 123.Vietnam Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 124.Vietnam Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 125.Vietnam Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 128.South Korea Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 129.South Korea Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 130.South Korea Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 133.Indonesia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 134.Indonesia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 135.Indonesia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 138.Philippines Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 139.Philippines Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 140.Philippines Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 143.Middle East & Africa Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 144.Middle East & Africa Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 145.Middle East & Africa Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 149.Saudi Arabia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 150.Saudi Arabia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 151.Saudi Arabia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 154.UAE Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 155.UAE Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 156.UAE Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 159.South Africa Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 160.South Africa Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 161.South Africa Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11203

Global breast reconstruction market is projected to witness a CAGR of 5.14% during the forecast period 2024-2031F, growing from USD 1.01 billion in 2023 to USD 1.51 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Growth in the global breast reconstruction market is driven by various factors such as the increasing prevalence of breast cancer among the global population and a growing number of breast reconstruction surgeries across the world. Technological advancements, the growing healthcare sector including the medical device industry and surgical industry along with increasing awareness campaigns by public and private organizations are the factors leading to the growth of this market globally. Moreover, favorable regulatory systems and reimbursement policies, the presence of several top players and collaborative venture activities, new entrants, and frequent product launches accelerate the growth of the global breast reconstruction market.

The global breast reconstruction market is undergoing robust growth primarily due to the increased prevalence of breast cancer among the global population. As this prevalence is increasing, there is an increase in the number of mastectomies performed every year. Breast reconstruction is the next essential step after mastectomy to restore the shape, size, symmetry, and contour of the breasts. Technological advancements in this industry such as the use of AI in performing breast reconstruction, increased research and development activities by the leading players further accelerating the global breast reconstruction market.

Frequent product launches by the market players along with a favorable regulatory framework play a pivotal role in boosting the global breast reconstruction market. There have been increased FDA approvals of breast implants, leading to improved medical conditions of the patients and surgical outcomes. Moreover, consistent collaboration activities such as mergers and acquisitions, partnerships, and distribution agreements between the organizations further propel the global breast reconstruction market.

For instance, in May 2022, GC Aesthetics, Inc., which is a leader in providing aesthetic solutions in the healthcare sector, announced the launch of "Nipple Areola Complex Reconstruction Implant" in partnership with FixNip LTD. This is implanted in just 15 minutes using minimally invasive surgery assists in enhancing patient satisfaction and contributes to the overall success of the breast reconstruction procedure.

Increasing Number of Breast Reconstruction Procedures

There has been a surge in the global breast reconstruction market due to the increasing prevalence of breast cancer worldwide. Breast cancer can lead to mastectomy, due to which patients are required to undergo breast reconstruction procedures. As there is increasing awareness among women regarding breast reconstruction options, there has been a significant increase in the number of breast reconstruction procedures.

For instance, an article, 'The International Awareness of Breast Reconstruction' published in the International Open Access Journal of the American Society of Plastic Surgeons, states that the number of breast reconstruction surgeries has significantly risen in recent decades. Additionally, with the growing awareness among women, it is anticipated that this will continue to rise in the forecast period as well. Moreover, technological advancements, favorable reimbursement policies, and an improved supportive regulatory framework further propel the global breast reconstruction market growth.

Technological Advancements

Growing demand for breast reconstruction treatment options led to increased research and development activities, which is further leading to innovation and technological advancements. Innovations such as the implementation of AI for breast reconstruction surgeries to improve surgical outcomes and the development of products that can enhance the aesthetic aspect of the surgery are driving market growth. Due to this, several leading players are consistently involved in developing innovative products in this market.

For instance, in April 2023, Establishment Labs Holdings Inc., which is a global medical technology company, announced the launch of its innovative product "Mia Femtech" for its Japan market, to bring advancement in the breast aesthetics market. Mia Femtech is the latest patented technology that can be executed in just 15 minutes via a minimally invasive procedure and does not require the use of general anesthesia. It gives natural and discreet results, and the patient can return to activities of daily life on the same day. Due to these innovative, beneficial technological advancements by the leading players, the global breast reconstruction market is expected to flourish.

Increased Demand for Implant-based Breast Reconstruction

Breast implant reconstructions hold a significant share in the market. Frequent technological advancements in the implants, faster procedure and recovery time, and simple procedures with fewer scars are some of the potential benefits of implant-based breast reconstruction. Due to this several market players are developing safe and efficient breast implants in their product portfolio.

For instance, in October 2023, MTF Biologics, which is a global nonprofit organization, announced that the U.S. FDA has approved an Investigational Device Exemption to commence a clinical investigation to validate the safety and efficacy of its latest launch implant, "FlexHD Pliable" for breast reconstruction. FlexHD Pliable is a human Acellular Dermal Matrix (ADM) implant for breast reconstruction. It is in the form of tissue that has been cut from a deeper layer of the dermis and afterward processed using an aseptic technique. This implant is the first ADM for breast reconstruction, that has been granted FDA approval to commence clinical trials. These innovative discoveries and product launches to enhance and expand growth in the implant-based breast reconstruction procedure are propelling the growth of the global breast reconstruction market.

Hospitals Hold a Major Share in the Global Breast Reconstruction Market

Among the end-user segment, hospitals hold a significant market share in the overall global breast reconstruction market. The increasing prevalence of breast cancer has led to an increased demand for breast reconstruction surgeries globally. Due to this, there has been a substantial increase in the requirement of hospitals to meet this growing requirement and for the timely execution of breast reconstruction surgeries. As a result, several countries are increasing the number of hospitals with proper surgical facilities.

For instance, in 2023, according to the American Hospital Association, there were 6,129 hospitals in the United States and more hospitals are under construction. Increased availability of highly efficient and safe breast implants, advanced technologies, and highly trained surgeons, along with the availability of end-to-end facilities for the patients, starting from assessment to follow-up, is leading to high demand for hospital-related services among the patients. This has led to the dominance of hospitals as an end-user segment.

North America Holds Significant Market Share

North America dominates the global breast reconstruction market, due to various factors such as the increasing cases of breast cancer in the region, which leads to mastectomy in most cases, due to which the demand for breast reconstruction is also on the rise. For instance, The American Cancer Society states that, the most common cancer in the U.S. is breast cancer. It states that in the year 2023, about 297,790 new cases of invasive breast cancer and approximately 55,720 new cases of Ductal Carcinoma In Situ (DCIS) were diagnosed among women in the U.S.

The increasing number of cases of breast cancer leads to an increase in mastectomy procedures that further leads to increased requirements for breast reconstruction. In addition, robust healthcare infrastructure, technological advancement in the region, favorable reimbursement policies, along with presence of major players such as Sientra, Inc. and Integra LifeSciences are other factors that are escalating the growth of this market in the region.

Future Market Scenario (2024-2031F)

The global breast reconstruction market is expected to grow in the future, due to several factors including the increasing prevalence of breast cancer, which increases the probability of mastectomies globally. Furthermore, technological advancements and innovation in breast reconstruction surgeries, will improve the quality of life of the patient and improve the surgical outcomes.

For instance, in January 2024, Establishment Labs Holdings Inc., which is a leading medical technology company, announced the launch of "Motiva Implants" for its China market. The Motiva Flora is a tissue expander implant, that is the only regulatory-approved expander in the world that uses radio-frequency technology. This product enhances breast reconstruction outcomes in the patients leading to increased patient satisfaction. Due to these frequent innovative launches by the leading players, the global breast reconstruction market is expected to flourish in the forecast period.

Key Players Landscape and Outlook

In the breast reconstruction market, several medical device manufacturers are consistently establishing strategic partnerships, and undergoing distribution agreements, which play an essential role in propelling the global breast reconstruction market's expansion. These partnerships enable companies to gain informative insights regarding market trends, access each other's knowledge, resources, markets, and technologies, and invest in research and development activities to bring safe and efficient breast reconstruction solutions such as breast implants. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative ventures promote innovation, expedite product development and contribute to the enduring and robust growth of the global market.

For instance, in December 2022, Integra LifeSciences Holdings Corporation, which is a global leader in medical technology, announced the successful acquisition of Surgical Innovation Associates. This strategic acquisition is expected to support the company in bringing advancement and innovation in implant-based breast reconstruction procedures and contribute to improving patient outcomes.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Breast Reconstruction Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2.By Procedure
    • 4.2.1. Implant Reconstruction
      • 4.2.1.1.Silicone Breast Implants
      • 4.2.1.2.Saline Breast Implants
    • 4.2.2. Tissue Reconstruction
    • 4.2.3. Others
  • 4.3.Product
    • 4.3.1. Breast Implant
    • 4.3.2. Tissue Expander
    • 4.3.3. Acellular Dermal Matrix
    • 4.3.4. Other Products
  • 4.4.By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Cosmetology Clinics
    • 4.4.3. Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Breast Reconstruction Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2. By Procedure
      • 5.1.2.1.Implant Reconstruction
      • 5.1.2.1.1.Silicone Breast Implants
      • 5.1.2.1.2.Saline Breast Implants
      • 5.1.2.2.Tissue Reconstruction
      • 5.1.2.3.Others
    • 5.1.3. By Product
      • 5.1.3.1.1.Breast Implant
      • 5.1.3.1.2.Tissue Expander
      • 5.1.3.1.3.Acellular Dermal Matrix
      • 5.1.3.1.4.Other Products
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Cosmetology Clinics
      • 5.1.4.3.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Procedure
      • 5.1.5.2.1.Implant Reconstruction
      • 5.1.5.2.1.1.Silicone Breast Implants
      • 5.1.5.2.1.2.Saline Breast Implants
      • 5.1.5.2.2.Tissue Reconstruction
      • 5.1.5.2.3.Others
      • 5.1.5.3.By Product
      • 5.1.5.3.1.Breast Implant
      • 5.1.5.3.2.Tissue Expander
      • 5.1.5.3.3.Acellular Dermal Matrix
      • 5.1.5.3.4.Other Products
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Cosmetology Clinics
      • 5.1.5.4.3.Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3.Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4.South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5.Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6.Market Mapping, 2023

  • 6.1.By Procedure
  • 6.2.By Product
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Allergan Aesthetics (AbbVie Inc.)
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Sientra, Inc.
  • 13.3.Medical Devices Business Services, Inc.
  • 13.4.RTI Surgical, Inc.
  • 13.5.Groupe SEBBIN SAS
  • 13.6.Integra LifeSciences
  • 13.7.GC Aesthetics
  • 13.8.Mentor Worldwide LLC
  • 13.9.Establishment Labs Holdings Inc.
  • 13.10.Polytech Health & Aesthetics GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer